| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Diagnostic dye poisoning |
Causative agent (attribute) |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Accidental diagnostic dye poisoning |
Causative agent (attribute) |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Intentional diagnostic dye poisoning |
Causative agent (attribute) |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagnostic dye poisoning of undetermined intent |
Causative agent (attribute) |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagnostic dye adverse reaction |
Causative agent (attribute) |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagnostic dye allergy |
Causative agent (attribute) |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Proxymetacaine hydrochloride+fluorescein sodium 0.5%/0.25% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Fluorescein sodium 1mg ophthalmic applicator strip |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Fluorescein sodium 2% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Fluorescein sodium 1% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Product containing rose bengal (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Rose bengal 1% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Fluorescein sodium and oxybuprocaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride+fluorescein sodium 4%/0.25% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Product containing fluorescein stain and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Benoxinate hydrochloride+fluorescein sodium 0.3%/0.125% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Medicinal product acting as diagnostic dye (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Product containing fluorescein stain (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Methylthioninium chloride-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Methylene blue 1% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Product containing lissamine green B stain (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Lissamine green ophthalmic strip |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Product containing trypan blue stain (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Trypan blue 0.06% ophthalmic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Fluorescein sodium 200mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Product containing tolonium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Diagnostic dye introduction |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagnostic dye - subcutaneous |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Methylthioninium chloride 65 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Diagn. dye introduction NOS |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Fluorescein + proparacaine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Diagnostic eye preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Fluorescein sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Opulets Fluorescein single-use eye drops 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Methylene blue 1% injection solution 5 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Methylene blue 1% injection solution 10 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Product containing indigotindisulfonate sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Indigotindisulfonate sodium 40mg injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Opulets Fluorescein |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Benoxinate hydrochloride+fluorescein sodium 0.4%/0.25% ophthalmic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Fluorescein sodium 0.6mg ophthalmic strip |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Rose bengal 1.3mg strip |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Fluorescein sodium 10% intraocular injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Fluorescein sodium 10% intraocular injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Fluorescein sodium 25% injection solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Fluorescein sodium 25% injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Pre-biopsy localisation of breast lesion using dye |
Using substance (attribute) |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
3 |
| Pre-biopsy localization of breast lesion using spot method |
Using substance (attribute) |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
3 |
| Pre-biopsy localisation of breast lesion using double dye method |
Using substance (attribute) |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
3 |
| Intrathecal injection of radiological dye |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Injection of dye into breast using ultrasound guidance (procedure) |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagnostic dye introduction |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagn. dye introduction NOS |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagnostic dye - subcutaneous |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Injection of dye into breast using ultrasound guidance (procedure) |
Direct substance |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagn. dye introduction NOS |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagnostic dye - subcutaneous |
Direct substance |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagnostic dye introduction |
Direct substance |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Intrathecal injection of radiological dye |
Direct substance |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagnostic dye allergy |
Causative agent (attribute) |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Intrathecal injection of radiological dye |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
2 |
| Localization of lesion with diagnostic dye using ultrasonographic guidance (procedure) |
Using substance (attribute) |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
2 |
| Cone beam CT guided localisation of lesion with diagnostic dye |
Using substance (attribute) |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Localization of lesion with diagnostic dye using fluoroscopic guidance (procedure) |
Using substance (attribute) |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Localization of sentinel lymph node using diagnostic dye (procedure) |
Using substance (attribute) |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Pre-biopsy localisation of breast lesion using dye |
Using substance (attribute) |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Pre-biopsy localization of breast lesion using spot method |
Using substance (attribute) |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
2 |
| Pre-biopsy localisation of breast lesion using double dye method |
Using substance (attribute) |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Isosulfan blue (substance) |
Is a |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]